Form 4 for ARWR ARROWHEAD PHARMACEUTICALS, INC.
Accepted 2026-06-17 21:44:15 ET · period of report 2026-06-15 · accession 0002141314-26-000004 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-17 21:44 | 2026-06-15 | ARWR | Cohen Matthew Gregory | Dir | A - Grant | $0.00 | +11.9K | 11.9K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2026-06-15 | A | A | 11,882 | $0.00 | 11,882 | D | — | — | (F1) Represents shares underlying restricted stock units with a grant date 06/15/2026, which will vest over three years. |